THE IMPACT OF THE GUT MICROBIOTA ON THE PATHOGENESIS AND MANAGEMENT OF INSULIN RESISTANCE
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4962Keywords:
Gut Microbiota, Insulin Resistance, Lipopolysaccharide, Probiotics, Short-Chain Fatty AcidsAbstract
Insulin resistance is a pathophysiological state, defined as a diminished biological response to insulin stimulation of target tissues, primarily the liver, muscles and adipose tissue. It has been identified as a significant factor in the development of certain diseases including type II diabetes mellitus, metabolic syndrome and obesity, and is concurrently associated with an elevated risk of cardiovascular disease and several cancers. A substantial amount of research has indicated a correlation between the occurrence of insulin resistance and imbalances in gut microbiota diversity. Intestinal dysbiosis has been demonstrated to contribute to a reduction in the synthesis of beneficial bacterial metabolites and to an increase in the production of pro-inflammatory cytokines and intestinal barrier permeability, allowing lipopolysaccharide to enter the bloodstream. These mechanisms have been shown to promote the development of inflammation and, consequently, insulin resistance. Therefore, a more profound comprehension of these processes is a matter of significance, as it may potentially facilitate the establishment of more specific and efficacious methods for the prevention and treatment of metabolic diseases.
References
Al Bander, Z., Nitert, M. D., Mousa, A., & Naderpoor, N. (2020). The gut microbiota and inflammation: An overview. International Journal of Environmental Research and Public Health, 17(20), 7618. https://doi.org/10.3390/ijerph17207618
Al-Habsi, N., Al-Khalili, M., Haque, S. A., Elias, M., Olqi, N. Al, & Al Uraimi, T. (2024). Health benefits of prebiotics, probiotics, synbiotics, and postbiotics. Nutrients, 16(22), 3955. https://doi.org/10.3390/nu16223955
Alqahtani, M. S. (2025). The gut microbiota–metabolic axis: Emerging insights from human and experimental studies on type 2 diabetes mellitus—A narrative review. Medicina, 61(11), 2017. https://doi.org/10.3390/medicina61112017
Aroor, A. R., McKarns, S., DeMarco, V. G., Jia, G., & Sowers, J. R. (2013). Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism, 62(11), 1543–1552. https://doi.org/10.1016/j.metabol.2013.07.001
Ballena-Caicedo, J., Zuzunaga-Montoya, F. E., Loayza-Castro, J. A., Bustamante-Rodríguez, J. C., Vásquez Romero, L. E. M., Tapia-Limonchi, R., De Carrillo, C. I. G., & Vera-Ponce, V. J. (2025). Global prevalence of insulin resistance in the adult population: A systematic review and meta-analysis. Frontiers in Endocrinology, 16. https://doi.org/10.3389/fendo.2025.1646258
Behall, K. M. (2006). Consumption of both resistant starch and β-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care, 29(5), 976–981. https://doi.org/10.2337/diacare.295976
Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., & Dumas, M.-E. (2016). Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine, 8(1), 42. https://doi.org/10.1186/s13073-016-0303-2
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., Waget, A., Delmée, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrières, J., Tanti, J.-F., Gibson, G. R., Casteilla, L., ... Burcelin, R. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772. https://doi.org/10.2337/db06-1491
Chen, Z., Radjabzadeh, D., Chen, L., Kurilshikov, A., Kavousi, M., Ahmadizar, F., Ikram, M. A., Uitterlinden, A. G., Zhernakova, A., Fu, J., Kraaij, R., & Voortman, T. (2021). Association of insulin resistance and type 2 diabetes with gut microbial diversity. JAMA Network Open, 4(7), e2118811. https://doi.org/10.1001/jamanetworkopen.2021.18811
Chong, S., Lin, M., Chong, D., Jensen, S., & Lau, N. S. (2025). A systematic review on gut microbiota in type 2 diabetes mellitus. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1486793
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021). Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut Pathogens, 13(1), 50. https://doi.org/10.1186/s13099-021-00446-0
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., Biddinger, S. B., Dutton, R. J., & Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559–563. https://doi.org/10.1038/nature12820
Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., & Mofid, V. (2012). Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition, 28(5), 539–543. https://doi.org/10.1016/j.nut.2011.08.013
Fan, Y., & Pedersen, O. (2021). Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology, 19(1), 55–71. https://doi.org/10.1038/s41579-020-0433-9
Freeman, A. M., Acevedo, L. A., & Pennings, N. (2025). Insulin resistance.
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., Verbeke, K., & Reid, G. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14(8), 491–502. https://doi.org/10.1038/nrgastro.2017.75
Gomaa, E. Z. (2020). Human gut microbiota/microbiome in health and diseases: A review. Antonie van Leeuwenhoek, 113(12), 2019–2040. https://doi.org/10.1007/s10482-020-01474-7
Hamari, N., Blaak, E. E., & Canfora, E. E. (2025). The impact of butyrate on glycemic control in animals and humans: A comprehensive semi-systemic review. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1603490
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. https://doi.org/10.1038/nrgastro.2014.66
Jethwani, P., & Grover, K. (2019). Gut microbiota in health and diseases – A review. International Journal of Current Microbiology and Applied Sciences, 8(08), 1586–1599. https://doi.org/10.20546/ijcmas.2019.808.187
Khan, S., & Jena, G. (2016). Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: A comparative study with metformin. Chemico-Biological Interactions, 254, 124–134. https://doi.org/10.1016/j.cbi.2016.06.007
Kim, J.-H., Kim, J. E., Liu, H.-Y., Cao, W., & Chen, J. (2008). Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. Journal of Biological Chemistry, 283(2), 708–715. https://doi.org/10.1074/jbc.M708568200
Kim, Y. A., Keogh, J. B., & Clifton, P. M. (2018). Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutrition Research Reviews, 31(1), 35–51. https://doi.org/10.1017/S095442241700018X
Lee, S., Choi, S.-P., Choi, H.-J., Jeong, H., & Park, Y.-S. (2024). A comprehensive review of synbiotics: An emerging paradigm in health promotion and disease management. World Journal of Microbiology and Biotechnology, 40(9), 280. https://doi.org/10.1007/s11274-024-04085-w
Maeshima, N., & Fernandez, R. C. (2013). Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Frontiers in Cellular and Infection Microbiology, 3. https://doi.org/10.3389/fcimb.2013.00003
Maki, K. C., Pelkman, C. L., Finocchiaro, E. T., Kelley, K. M., Lawless, A. L., Schild, A. L., & Rains, T. M. (2012). Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. The Journal of Nutrition, 142(4), 717–723. https://doi.org/10.3945/jn.111.152975
Markowiak, P., & Śliżewska, K. (2017). Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9(9), 1021. https://doi.org/10.3390/nu9091021
Mehta, N. N., McGillicuddy, F. C., Anderson, P. D., Hinkle, C. C., Shah, R., Pruscino, L., Tabita-Martinez, J., Sellers, K. F., Rickels, M. R., & Reilly, M. P. (2010). Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes, 59(1), 172–181. https://doi.org/10.2337/db09-0367
Murphy, E. A., Velazquez, K. T., & Herbert, K. M. (2015). Influence of high-fat diet on gut microbiota. Current Opinion in Clinical Nutrition and Metabolic Care, 18(5), 515–520. https://doi.org/10.1097/MCO.0000000000000209
Rehman, K., Akash, M. S. H., Liaqat, A., Kamal, S., Qadir, M. I., & Rasul, A. (2017). Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Critical Reviews in Eukaryotic Gene Expression, 27(3), 229–236. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2017019712
Robles-Alonso, V., & Guarner, F. (2013). [Progress in the knowledge of the intestinal human microbiota]. Nutricion Hospitalaria, 28(3), 553–557. https://doi.org/10.3305/nh.2013.28.3.6601
Rotter, V., Nagaev, I., & Smith, U. (2003). Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. The Journal of Biological Chemistry, 278(46), 45777–45784. https://doi.org/10.1074/jbc.M301977200
Russo, F., Riezzo, G., Chiloiro, M., De Michele, G., Chimienti, G., Marconi, E., D’Attoma, B., Linsalata, M., & Clemente, C. (2010). Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers. Current Pharmaceutical Design, 16(7), 825–831. https://doi.org/10.2174/138161210790883570
Salazar, N., Arboleya, S., Fernández-Navarro, T., de los Reyes-Gavilán, C. G., Gonzalez, S., & Gueimonde, M. (2019). Age-associated changes in gut microbiota and dietary components related with the immune system in adulthood and old age: A cross-sectional study. Nutrients, 11(8), 1765. https://doi.org/10.3390/nu11081765
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002). Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 51(12), 3391–3399. https://doi.org/10.2337/diabetes.51.12.3391
Singh, V., Lee, G., Son, H., Koh, H., Kim, E. S., Unno, T., & Shin, J.-H. (2023). Butyrate producers, “The sentinel of gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Frontiers in Microbiology, 13. https://doi.org/10.3389/fmicb.2022.1103836
Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2016). Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the West Virginian population. International Journal of Medical Sciences, 13(1), 25–38. https://doi.org/10.7150/ijms.13800
Xiao, X., Sankaranarayanan, K., & Khosla, C. (2017). Biosynthesis and structure–activity relationships of the lipid A family of glycolipids. Current Opinion in Chemical Biology, 40, 127–137. https://doi.org/10.1016/j.cbpa.2017.07.008
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry, 288(35), 25088–25097. https://doi.org/10.1074/jbc.M113.452516
Yadav, M. K., Kumari, I., Singh, B., Sharma, K. K., & Tiwari, S. K. (2022). Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Applied Microbiology and Biotechnology, 106(2), 505–521. https://doi.org/10.1007/s00253-021-11646-8
Yu, J., Wu, Y., Zhu, Z., & Lu, H. (2025). The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: A systematic review. Nutrition Journal, 24(1), 17. https://doi.org/10.1186/s12937-024-01060-x
Zamyatina, A., & Heine, H. (2020). Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4/11 mediated inflammatory pathways. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.585146
Zamyatina, A., & Heine, H. (2021). Corrigendum: Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4/11 mediated inflammatory pathways. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.649442
Zhernakova, D. V., Wang, D., Liu, L., Andreu-Sánchez, S., Zhang, Y., Ruiz-Moreno, A. J., Peng, H., Plomp, N., Del Castillo-Izquierdo, Á., Gacesa, R., Lopera-Maya, E. A., Temba, G. S., Kullaya, V. I., van Leeuwen, S. S., Aguirre-Gamboa, R., Deelen, P., Franke, L., Kuivenhoven, J. A., Nolte, I. M., ... Fu, J. (2024). Host genetic regulation of human gut microbial structural variation. Nature, 625(7996), 813–821. https://doi.org/10.1038/s41586-023-06893-w
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ivanna Lazarchuk, Mateusz Sydor, Wojciech Plizga, Zuzanna Lepa, Paulina Kalemba, Patrycja Lipska, Antoni Majda
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
